Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | XBP1 | P17861 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TAOK1 | Q7L7X3 | 3/20 | 0.41 |
| ▸ | TAOK3 | Q9H2K8 | 3/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3151513 | 0.92 | ALDH1A1 (0.57) | HTTALDH1A1XBP1RAB9AMEN1 | |
| SCHEMBL19658774 | 0.75 | ALDH1A1 (0.78) | HTTALDH1A1XBP1RAB9AMEN1 | |
| SCHEMBL4565540 | 0.75 | HTT (0.61) | HTTALDH1A1XBP1RAB9AMEN1 | |
| SCHEMBL3217680 | 0.74 | ALDH1A1 (0.49) | HTTALDH1A1XBP1RAB9ATRPM8 | |
| Oxalic Acid SCHEMBL10445493 | 0.73 | HTT (0.55) | HTTALDH1A1XBP1RAB9AMEN1 | |
| SCHEMBL17577868 | 0.72 | ALDH1A1 (0.50) | HTTALDH1A1XBP1RAB9AMEN1 | |
| SCHEMBL16138349 | 0.72 | ALDH1A1 (0.50) | HTTALDH1A1XBP1RAB9AMEN1 | |
| SCHEMBL1568314 | 0.72 | ALDH1A1 (0.58) | HTTALDH1A1XBP1RAB9AMEN1 | |
| SCHEMBL8181427 | 0.72 | HTT (0.48) | HTTALDH1A1XBP1RAB9ASIGMAR1 | |
| SCHEMBL3330158 | 0.72 | MEN1 (0.71) | HTTALDH1A1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100004339-A1 | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists | OY JUVANTIA PHARMA LTD. (FI) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004339-A1 | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists | SSTR4, SSTR1, SSTR3 | HTT 2132/4885ALDH1A1 4124/4885XBP1 2950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.